Cargando…

The Synthetic Antimicrobial Peptide 19-2.5 Interacts With Heparanase and Heparan Sulfate in Murine Sepsis In Vivo and in Human Sepsis Ex Vivo

Detalles Bibliográficos
Autores principales:	Martin, L, Doemming, S, Humbs, A, Heinbockel, L, Brandenburg, K, Marx, G, Schürholz, T
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2015
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4796312/ http://dx.doi.org/10.1186/2197-425X-3-S1-A516

Ejemplares similares

The Synthetic Antimicrobial Peptide 19-2.5 Interacts with Heparanase and Heparan Sulfate in Murine and Human Sepsis
por: Martin, Lukas, et al.
Publicado: (2015)

Peptide 19-2.5 Inhibits Heparan Sulfate-Triggered Inflammation in Murine Cardiomyocytes Stimulated with Human Sepsis Serum
por: Martin, Lukas, et al.
Publicado: (2015)

The anti-inflammatory effect of the synthetic antimicrobial peptide 19-2.5 in a murine sepsis model: a prospective randomized study
por: Schuerholz, Tobias, et al.
Publicado: (2013)

Heparan sulfates and heparan sulfate binding proteins in sepsis
por: Liao, Yi-En, et al.
Publicado: (2023)

Adrenomedullin in plasma of surgical ICU-patients with sepsis - a pilot study
por: Simon, T-P, et al.
Publicado: (2015)

Heparan Sulfate and Heparanase as Modulators of Breast Cancer Progression
por: Gomes, Angélica M., et al.
Publicado: (2013)

Elucidating the Consequences of Heparan Sulfate Binding by Heparanase 2
por: Gross-Cohen, Miriam, et al.
Publicado: (2021)

Pro-enkephalin in plasma of surgical icu-patients with sepsis - a pilot study
por: Doemming, S, et al.
Publicado: (2015)

Neuraminidase inhibitors rewire neutrophil function in vivo in murine sepsis and ex vivo in COVID-19
por: de Oliveira Formiga, Rodrigo, et al.
Publicado: (2022)

Therapeutical Administration of Peptide Pep19-2.5 and Ibuprofen Reduces Inflammation and Prevents Lethal Sepsis
por: Heinbockel, Lena, et al.
Publicado: (2015)

Heparanase Facilitates Cell Adhesion and Spreading by Clustering of Cell Surface Heparan Sulfate Proteoglycans
por: Levy-Adam, Flonia, et al.
Publicado: (2008)

Mechanisms of heparanase inhibition by the heparan sulfate mimetic PG545 and three structural analogues()
por: Hammond, Edward, et al.
Publicado: (2013)

Heparan sulfate proteoglycans and heparanases in Alzheimer's disease: current outlook and potential therapeutic targets
por: Lorente-Gea, Laura, et al.
Publicado: (2017)

Lipoproteins/peptides are sepsis-inducing toxins from bacteria that can be neutralized by synthetic anti-endotoxin peptides
por: de Tejada, Guillermo Martinez, et al.
Publicado: (2015)

PG545, a Heparan Sulfate Mimetic, Reduces Heparanase Expression In Vivo, Blocks Spontaneous Metastases and Enhances Overall Survival in the 4T1 Breast Carcinoma Model
por: Hammond, Edward, et al.
Publicado: (2012)

Extracorporeal immune cell therapy of sepsis: ex vivo results
por: Klinkmann, Gerd, et al.
Publicado: (2022)

The Role of Heparanase and Sulfatases in the Modification of Heparan Sulfate Proteoglycans within the Tumor Microenvironment and Opportunities for Novel Cancer Therapeutics
por: Hammond, Edward, et al.
Publicado: (2014)

Soluble Heparan Sulfate Fragments Generated by Heparanase Trigger the Release of Pro-Inflammatory Cytokines through TLR-4
por: Goodall, Katharine J., et al.
Publicado: (2014)

Synthetic Site-Selectively Mono-6-O-Sulfated Heparan Sulfate Dodecasaccharide Shows Anti-Angiogenic Properties In Vitro and Sensitizes Tumors to Cisplatin In Vivo
por: Avizienyte, Egle, et al.
Publicado: (2016)

Endothelial Heparan Sulfate Mediates Hepatic Neutrophil Trafficking and Injury during Staphylococcus aureus Sepsis
por: Golden, Gregory J., et al.
Publicado: (2021)

Antimicrobial Peptides in Human Sepsis
por: Martin, Lukas, et al.
Publicado: (2015)

Heparanase mediates renal dysfunction during early sepsis in mice
por: Lygizos, Melissa I, et al.
Publicado: (2013)

Role of heparanase in sepsis‑related acute kidney injury (Review)
por: Li, Jian-Chun, et al.
Publicado: (2023)

Using heparan sulfate octadecasaccharide (18-mer) as a multi-target agent to protect against sepsis
por: Liao, Yi-En, et al.
Publicado: (2023)

In vivo importance of heparan sulfate-binding glycoproteins for murid herpesvirus-4 infection
por: Gillet, Laurent, et al.
Publicado: (2009)

Heparan Sulfate and Heparan Sulfate Proteoglycans in Cancer Initiation and Progression
por: Nagarajan, Arvindhan, et al.
Publicado: (2018)

The Effect of a Synthetic Heparan Sulfate on the Healing of Colonic Anastomoses
por: Nerstrøm, Malene, et al.
Publicado: (2017)

Histone H4 induces heparan sulfate degradation by activating heparanase in chlorine gas-induced acute respiratory distress syndrome
por: Zhang, Yanlin, et al.
Publicado: (2022)

Distribution of Heparan Sulfate Oligosaccharides in Murine Mucopolysaccharidosis Type IIIA
por: Mason, Kerryn, et al.
Publicado: (2014)

The synthetic antimicrobial peptide 19-2.5 attenuates septic cardiomyopathy and prevents down-regulation of SERCA2 in polymicrobial sepsis
por: Martin, Lukas, et al.
Publicado: (2016)

Defective Neutrophil Function in Patients with Sepsis Is Mostly Restored by ex vivo Ascorbate Incubation
por: Sae-khow, Kritsanawan, et al.
Publicado: (2020)

Conditional ablation of heparan sulfate expression in stromal fibroblasts promotes tumor growth in vivo
por: Niwa, Ayumi, et al.
Publicado: (2023)

Synthetic Heparan Sulfate Oligosaccharides Inhibit Endothelial Cell Functions Essential for Angiogenesis
por: Cole, Claire L., et al.
Publicado: (2010)

Single‐Molecule Fluorescence Detection of a Synthetic Heparan Sulfate Disaccharide
por: Dalton, Charlotte E., et al.
Publicado: (2016)

Synthetic anticoagulant heparan sulfate attenuates liver ischemia reperfusion injury
por: Arnold, Katelyn, et al.
Publicado: (2020)

Heparan sulfate proteoglycans and cancer
por: Blackhall, F H, et al.
Publicado: (2001)

Heparan sulfate proteoglycan induces the production of NO and TNF-α by murine microglia
por: Bussini, Simona, et al.
Publicado: (2005)

Anti-Infective and Anti-Inflammatory Mode of Action of Peptide 19-2.5
por: Heinbockel, Lena, et al.
Publicado: (2021)

A VP1 mutation acquired during an enterovirus 71 disseminated infection confers heparan sulfate binding ability and modulates ex vivo tropism
por: Tseligka, Eirini D., et al.
Publicado: (2018)

Heparanase inhibition leads to improvement in patients with acute gastrointestinal injuries induced by sepsis
por: Chen, Ting-Ting, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_c6a3ids3n1phu7phnld8b6ra5p